STATCenter·
STAT+: FDA approves Merck’s oral PCSK9 drug, a first
Kalshi allows bets on clinical trial outcomes, Eli Lilly buys a psychedelic medicine, and more biotech news from The Readout
Read at STAT →
Health · 1 sources covering this
STAT+: FDA approves Merck’s oral PCSK9 drug, a first
Kalshi allows bets on clinical trial outcomes, Eli Lilly buys a psychedelic medicine, and more biotech news from The Readout
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/72410e49316d0b4bb4dec08bdd4a335f35c0e2ba" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: FDA approves Merck’s oral PCSK9 drug, a first"></iframe>
